Nuro, a global leader in non-invasive neurotechnology has announced it has received a fourth patent for its PAD, a wireless portable neurological helmet technology for early detection and continuous monitoring of various neurological disorders including Alzheimer’s disease.
Unlike traditional fMRI and PET scanners, which require investments, dedicated space and personnel, the device is designed to support primary care physicians with an ultra-rapid scan of key regions of the brain, assisted by live analysis, classification and immediate results sharing through deep learning AI methodologies.
Nuro hopes its technology will give unprecedented insights to support healthcare systems. As well as, becoming a source of de-identified data across various neurological conditions and timelines.
“We aim to assist patients-at-risk and allow them to start tracking diligently, precisely and regularly with their general practitioners what is happening to their brain before they eventually get referred to more specialised institutions which may only see them once or twice a year,” said Francois Gand, founder and CEO of Nuro and the creator of the PAD.
Click here to read the original news story.